ArticlePloS one2025
A scoping review protocol: Neuropsychological development in pediatric ophthalmology patients with social determinants of health analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGlobally, ocular diseases have a substantial prevalence and impose a significant disease burden. Specifically, ocular diseases can negatively impact neuropsychological development for pediatric patients, including academic, social, and mental health as well as quality of life. Neuropsychological development is important, because it impacts cognitive functioning and learning, emotional and behavioral regulation, social interactions and communication, executive functions later in life, and long-term health and well-being. Detriments in neuropsychological development can be modulated by the intricate social determinants of health (SDOH) in a patient's environment, potentially leading to exacerbated outcomes and disparities. We will conduct a scoping review with the aim of evaluating how SDOH influences the impact of ocular diseases on the neuropsychological development of pediatric patients. METHODS AND ANALYSIS: Using a comprehensive search strategy, all relevant literature will be extracted from the following electronic databases: Cochrane Central Register of Controlled Trials (WileyOnline interface), Embase (Elsevier interface), Europe PMC, Medline (Ovid Interface), PsycInfo (EBSCO interface), and Scopus (Elsevier interface). Inclusion criteria consist of ocular disease, neuropsychiatric development, pediatric population, and social determinants of health. Covidence (Veritas Health Innovation Ltd, Melbourne, Australia) review software will be used to screen articles that meet the inclusion criteria. Extracted articles will be classified according to national income level and universal healthcare index, type of ocular disease, neuropsychological category, and social determinants of health domain. Data analysis will include a quantitative report on the percentage classification of articles by each ocular, neuropsychological, and SDOH domain category. Sub-categorization of article count by national location, income level, and presence of universal healthcare will be analyzed for each explored and observed SDOH domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.